Targeting the T cell immunoglobulin and ITIM domains (TIGIT) immune checkpoint has a future role in the management of multiple myeloma, early research at the QIMR Berghofer Medical Research Institute in Queensland suggests. In a proof of concept study researchers at QIMR have demonstrated that TIGIT expression is upregulated in immune cells in both animal models challenged ...
Checkpoint blockade shows promise for multiple myeloma
By Mardi Chapman
25 Jul 2018